A Stone

501 total citations
22 papers, 325 citations indexed

About

A Stone is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A Stone has authored 22 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A Stone's work include Cancer Genomics and Diagnostics (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Statistical Methods in Clinical Trials (4 papers). A Stone is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Statistical Methods in Clinical Trials (4 papers). A Stone collaborates with scholars based in United Kingdom, United States and Australia. A Stone's co-authors include Jeffrey D. Helterbrand, William D. Bushnell, Ohad Amit, Jonathan Denne, Hans-Ulrich Burger, Frank Mannino, Jane Robertson, David Cunningham, Eric Van Cutsem and Torsten Börchers and has published in prestigious journals such as Journal of Clinical Oncology, Developmental Biology and British Journal of Cancer.

In The Last Decade

A Stone

21 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Stone United Kingdom 8 134 126 69 54 39 22 325
M. Savina France 7 149 1.1× 200 1.6× 15 0.2× 26 0.5× 22 0.6× 10 275
Jiabu Ye United States 9 226 1.7× 162 1.3× 51 0.7× 110 2.0× 18 0.5× 19 339
Shengchun Kong United States 9 312 2.3× 227 1.8× 72 1.0× 47 0.9× 17 0.4× 15 522
Tom Morris United Kingdom 7 38 0.3× 311 2.5× 43 0.6× 67 1.2× 19 0.5× 11 466
Chin-Yu Lin United States 7 133 1.0× 327 2.6× 16 0.2× 25 0.5× 16 0.4× 8 494
Д. В. Комов Russia 7 158 1.2× 28 0.2× 15 0.2× 37 0.7× 23 0.6× 21 248
Thomas H. Douglas United States 10 129 1.0× 411 3.3× 18 0.3× 69 1.3× 15 0.4× 12 503
Marie Hjälm-Eriksson Sweden 8 113 0.8× 367 2.9× 30 0.4× 111 2.1× 21 0.5× 17 455
Carmela Caballero Belgium 10 164 1.2× 140 1.1× 8 0.1× 84 1.6× 17 0.4× 33 357
Howard West United States 8 111 0.8× 77 0.6× 12 0.2× 88 1.6× 16 0.4× 12 225

Countries citing papers authored by A Stone

Since Specialization
Citations

This map shows the geographic impact of A Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Stone more than expected).

Fields of papers citing papers by A Stone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Stone. The network helps show where A Stone may publish in the future.

Co-authorship network of co-authors of A Stone

This figure shows the co-authorship network connecting the top 25 collaborators of A Stone. A scholar is included among the top collaborators of A Stone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Stone. A Stone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stone, A, et al.. (2025). Meta-UNet: enhancing skin-lesion segmentation with multimodal feature integration and uncertainty estimation. International Journal of Computer Assisted Radiology and Surgery. 20(9). 1911–1922. 1 indexed citations
2.
Stone, A, et al.. (2023). Evaluation of breast tumor morphologies from African American and Caucasian patients. Computational and Structural Biotechnology Journal. 21. 3459–3465. 1 indexed citations
3.
Stone, A, et al.. (2021). Evaluation of early post-natal pig mammary gland development and human breast cancer gene expression. Developmental Biology. 481. 95–103. 1 indexed citations
5.
Stone, A, et al.. (2018). Exaggeration of PFS by blinded, independent, central review (BICR). Annals of Oncology. 30(2). 332–338. 13 indexed citations
6.
Ruiz-Valdepeñas, Andrea, Katrin Heider, Wendi Qian, et al.. (2017). MA 11.02 Circulating Tumor DNA in Early Stage NSCLC: High Sensitivity Analysis in Low Burden Disease. LUCID Study Update. Journal of Thoracic Oncology. 12(11). S1843–S1844. 2 indexed citations
7.
Cunningham, David, Ralph Wong, Geert D’Haens, et al.. (2013). Cediranib with mFOLFOX6 vs bevacizumab with mFOLFOX6 in previously treated metastatic colorectal cancer. British Journal of Cancer. 108(3). 493–502. 38 indexed citations
8.
Stone, A, et al.. (2012). Do patients above the age of 75 with distal radial fractures treated with a DVR plate have more complications?. Injury Extra. 43(10). 114–114. 1 indexed citations
9.
Stone, A, et al.. (2012). Attenuation of treatment effect due to measurement variability in assessment of progression‐free survival. Pharmaceutical Statistics. 11(5). 394–402. 10 indexed citations
10.
Stone, A, William D. Bushnell, Daniel J. Sargent, et al.. (2011). Research outcomes and recommendations for the assessment of progression in cancer clinical trials from a PhRMA working group. European Journal of Cancer. 47(12). 1763–1771. 42 indexed citations
11.
Schmoll, Hans‐Joachim, et al.. (2011). Application of adaptive study designs: Phase II and III results from the cediranib (CED) HORIZON (HZ) II and III studies.. Journal of Clinical Oncology. 29(15_suppl). 3633–3633. 2 indexed citations
12.
Amit, Ohad, Frank Mannino, A Stone, et al.. (2011). Blinded independent central review of progression in cancer clinical trials: Results from a meta-analysis. European Journal of Cancer. 47(12). 1772–1778. 78 indexed citations
13.
Cunningham, David, G D’Haens, Jean‐Yves Douillard, et al.. (2008). A phase II, double-blind, randomized multicenter study of cediranib with FOLFOX versus bevacizumab with FOLFOX in patients with previously treated metastatic colorectal cancer (mCRC): Final PFS results. Journal of Clinical Oncology. 26(15_suppl). 4028–4028. 26 indexed citations
14.
Stone, A, Helen Jones, M.G. Giles, Julia M.W. Gee, & Robert I. Nicholson. (2008). Anti-oestrogen therapy switches off tumour suppressors and proapoptotic genes in breast cancer and reveals a new therapeutic opportunity. Breast Cancer Research. 10(S2). 2 indexed citations
15.
Oliver, Robert, Catherine Wheeler, Peter Langmuir, I. Melezínek, & A Stone. (2004). Evaluation of the role of body-surface-area dose adjustment of ZD6126, a novel vascular-targeting agent. Journal of Clinical Oncology. 22(14_suppl). 3065–3065. 1 indexed citations
16.
Stone, A. (2003). For-fee hot spots strive to make Wi-Fi pay. IEEE Pervasive Computing. 2(3). 3–7. 4 indexed citations
17.
Wirth, Manfred P., C. Tyrrell, Michael B. Wallace, et al.. (2001). Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression. Urology. 58(2). 146–150. 57 indexed citations
18.
Growcott, J, et al.. (2000). Sensitivity of repeated interdigital web pinching to detect antinociceptive effects of ibuprofen. British Journal of Clinical Pharmacology. 49(4). 331–336. 7 indexed citations
19.
Stone, A & R C Bone. (1989). Successful weaning from mechanical ventilation. Postgraduate Medicine. 86(5). 315–319. 5 indexed citations
20.
Stone, A. (1964). The Tabanidae (Diptera) of Florida. Bulletin of the Entomological Society of America. 10(4). 234–234. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026